World Alzheimer Report 2026: A new era in dementia clinical trials
The latest World Alzheimer Report from Alzheimer’s Disease International (ADI) explores a rapidly changing landscape for dementia research and clinical trials.
After decades of limited treatment options, there is now significant momentum in dementia research – from disease-modifying treatments and earlier diagnosis to blood-based biomarkers and new approaches to prevention and support.
But the report raises an important question:
How do we ensure that advances in research translate into meaningful improvements in everyday life for people living with a dementia?
This is where the work of the Dementia Services Development Centre (DSDC) has a particularly important role to play.
For more than 30 years, DSDC has focused on connecting research, practice, education, design and policy to improve the lives of people living with a dementia. Its work demonstrates that evidence only becomes truly meaningful when it is translated into the environments, services and support people experience every day.
The 2026 report makes a similar argument.
It calls for clinical trials to measure outcomes that matter to people – not simply biological or cognitive changes, but independence, daily functioning, communication, quality of life and the impact on families and care partners. It also calls for people living with a dementia and care partners to be involved much earlier in the design of research.
This resonates strongly with the principles underpinning DSDC's work.
Research must translate into lived experience.
DSDC's work in dementia-inclusive design is a powerful example.
Through tools such as the Environments for Ageing and Dementia Design Assessment Tool (EADDAT), research and evidence about the relationship between people and their environments can be translated into practical changes to the places where people live, work and spend time.
The same principle applies to practice.
Research should not remain within academic papers or clinical trial protocols. It needs to influence how we communicate, how we provide support, how we design environments, how we educate professionals and how we develop services.
The 2026 report also highlights the importance of involving people living with a dementia throughout the research process – from identifying priorities and designing studies through to deciding what outcomes matter.
That is an important reminder for all of us working in dementia.
Innovation isn't simply about discovering something new.
It is about taking what we learn and asking:
What does this mean for the person living with a dementia?
What does it mean for their family and those supporting them?
And how do we translate this evidence into better everyday experiences?
This is the space where research, practice and lived experience meet – and it remains central to the work of DSDC.
